Pharma Industry/Biotech Industry News

Tightening Regulations And Raising Standards In UK Marketing Communications: The New ABPI Code Of Practice 2008 Explained

Sat, 21 Jun 2008 19:40:03 GMT

KeywordPharma Expert Reviews are FREELY available to download and pass on thanks to support from relevant sponsors.

U.S. EPA Licenses Simulations Plus' ADMET Predictor trade; Software

Fri, 20 Jun 2008 15:40:08 GMT

Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of software for pharmaceutical discovery and development, announced that it has received a purchase order from the U.

Full text

Incentives To Develop Medicines For Neglected Diseases Highlighted At 2008 BIO International Convention

Fri, 20 Jun 2008 15:40:07 GMT

The Biotechnology Industry Organization (BIO) announced the release of a paper outlining incentives to encourage innovation for neglected diseases.

Full text

CCA Responds To Government And Industry Price Deal

Fri, 20 Jun 2008 15:40:07 GMT

The CCA has issued its initial response to today's announcement that a significant deal has been reached by the Government and the pharmaceutical industry on parts of the new Pharmaceutical Price Regulation Scheme.

Full text

Biologics Sales Increased 12.5 In 2007 To 75B, Nearly Double 6.4 Increase Of Traditional Pharmaceuticals

Fri, 20 Jun 2008 15:40:06 GMT

Worldwide sales of biologic medications increased by 12.5% in 2007 to $75 billion, nearly double the 6.

Full text

BIO And ABLE-India Announce First Biotechnology Partnering Event In India

Fri, 20 Jun 2008 15:40:05 GMT

The Biotechnology Industry Organization (BIO) and the Association of Biotechnology Led Enterprises (ABLE), a national forum that represents the Indian biotechnology sector, today announced a two-day annual biotechnology partnering meeting to be held in Hyderabad, India.

Full text

GE Animal Technologies Promise To Enhance Human Health

Fri, 20 Jun 2008 15:40:04 GMT

Genetically engineered (GE) animals provide innovative technologies that are transforming public health through biomedical, food and environmental applications, according to a scientific report released at the BIO 2008 International Convention .

Full text

Euro Nippon Kayaku GmbH Withdraws Its Marketing Authorisation Application For Spanidin gusperimus , Europe

Fri, 20 Jun 2008 15:40:03 GMT

The European Medicines Agency (EMEA) has been formally notified by Euro Nippon Kayaku GmbH of its decision to withdraw its application for a centralised marketing authorisation application for the medicine Spanidin (gusperimus) 50 mg/ml powder for solution for injection.

Full text

HealthLinx And InSymbiosis To Co-Develop Therapeutic For Lung Disease

Fri, 20 Jun 2008 15:40:02 GMT

HealthLinx Limited (ASX:HTX) and Canadian-based InSymbiosis Discovery Inc (InSymbiosis) have signed a Letter of Intent to co-develop HTX's peptide therapeutic CR014 and related compounds for applications in Acute Respiratory Distress Syndrome (ARDS) and Acute Lung Injury.

Full text

Drugs With Fewer Side Effects

Thu, 19 Jun 2008 12:20:12 GMT

A Duke University chemist has apparently solved a long-standing frustration in creating certain synthetic molecules that make up drugs, which could lead to better drugs with fewer side effects.

Full text